Vegf-binding protein for blockade of angiogenesis
作者： Szofia S. Bullain , Bob Carter , Richard C. Mulligan , Jeng-Shin Lee
DOI:
关键词:
摘要: Provided are chimeric VEGF-binding proteins and nucleic acids (e.g., a vector) encoding proteins, methods host cells for producing these acids, pharmaceutical compositions containing acids. Also provided of treating an angiogenic disease or disorder that include administering at least one the protein.
lens.org 参考文章(47)
Terence R Flotte, Mark L Brantly, L Terry Spencer, Barry J Byrne, Carolyn T Spencer, Dawn J Baker, Margaret Humphries, Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Human Gene Therapy. ,vol. 15, pp. 93- 128 ,(2004) , 10.1089/10430340460732490
Terri Davis‐Smyth, Helen Chen, Jeanie Park, Leonard G Presta, Napoleone Ferrara, None, The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. The EMBO Journal. ,vol. 15, pp. 4919- 4927 ,(1996) , 10.1002/J.1460-2075.1996.TB00872.X
Seymour Yolles, Biodegradable polymeric article for dispensing drugs ,(1970)
Plasmids for therapy and vaccination : Wiley-VCH. ,(2001) , 10.1002/9783527612833
Thomas Harding, Minh Nguyen, Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors ,(2006)
James P. Fandl, Thomas J. Daly, Nicholas J. Papadopoulos, Fusion protein capable of binding VEGF ,(2003)
Quing Miao, William C. Sessa, Nogo-b receptor ,(2007)
John E. Coligan, Current Protocols in Protein Science ,(1996)
Candace Summerford, Richard Jude Samulski, Viral receptors and vector purification: New approaches for generating clinical-grade reagents Nature Medicine. ,vol. 5, pp. 587- 588 ,(1999) , 10.1038/8470